{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:00:40Z","timestamp":1780142440959,"version":"3.54.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaophthalmol.2020.0647","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T15:44:45Z","timestamp":1585842285000},"page":"536","source":"Crossref","is-referenced-by-count":8,"title":["Pointwise Methods to Measure Long-term Visual Field Progression in Glaucoma"],"prefix":"10.1001","volume":"138","author":[{"given":"Diana","family":"Salazar","sequence":"first","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Morales","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rabiolo","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"},{"name":"Department of Ophthalmology, University Vita-Salute, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Capistrano","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lin","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmonem A.","family":"Afifi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"},{"name":"Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, UCLA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouros","family":"Nouri-Mahdavi","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Caprioli","sequence":"additional","affiliation":[{"name":"Glaucoma Division, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"eoi200019r1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162229","article-title":"Number of people blind or visually impaired by glaucoma worldwide and in world regions 1990-2010: a meta-analysis.","volume":"11","author":"Bourne","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"eoi200019r2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi200019r3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1034\/j.1600-0420.2003.00070.x","article-title":"Measuring visual field progression in the Early Manifest Glaucoma Trial.","volume":"81","author":"Heijl","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"eoi200019r4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors.","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi200019r5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0161-6420(94)31171-7","article-title":"Advanced Glaucoma Intervention Study, 2: visual field test scoring and reliability.","volume":"101","author":"AGIS investigators","year":"1994","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi200019r6","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0161-6420(03)00541-4","article-title":"Evaluating several sources of variability for standard and SWAP visual fields in glaucoma patients, suspects, and normals.","volume":"110","author":"Blumenthal","year":"2003","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi200019r7","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1167\/iovs.12-10268","article-title":"Factors that influence standard automated perimetry test results in glaucoma: test reliability, technician experience, time of day, and season.","volume":"53","author":"Junoy Montolio","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi200019r8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bjophthalmol-2014-305210","article-title":"Measuring rates of structural and functional change in glaucoma.","volume":"99","author":"Nouri-Mahdavi","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi200019r9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/aos.2013.91.issue-5","article-title":"Rates of visual field progression in clinical glaucoma care.","volume":"91","author":"Heijl","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"eoi200019r10","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Natural history of open-angle glaucoma.","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi200019r11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/bjophthalmol-2017-310635","article-title":"Tolerable rates of visual field progression in a population-based sample of patients with glaucoma.","volume":"102","author":"Salonikiou","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi200019r12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.7.6.14","article-title":"A method to measure the rate of glaucomatous visual field change.","volume":"7","author":"Caprioli","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"eoi200019r13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.8.5.2","article-title":"Comparison of methods to detect glaucomatous visual field progression.","volume":"8","author":"Rabiolo","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"20","key":"eoi200019r14","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"eoi200019r15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajo.2019.01.019","article-title":"Cataract surgery and rate of visual field progression in primary open-angle glaucoma.","volume":"201","author":"Kim","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi200019r16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1167\/iovs.15-18000","article-title":"The effect of limiting the range of perimetric sensitivities on pointwise assessment of visual field progression in glaucoma.","volume":"57","author":"Gardiner","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"eoi200019r17","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1167\/iovs.02-1171","article-title":"Comparison of different methods for detecting glaucomatous visual field progression.","volume":"44","author":"Vesti","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"eoi200019r18","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archopht.117.9.1137","article-title":"Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.","volume":"117","author":"Katz","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"eoi200019r19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ophtha.2019.01.029","article-title":"Agreement and predictors of discordance of 6 visual field progression algorithms.","volume":"126","author":"Saeedi","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi200019r20","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1167\/iovs.12-10049","article-title":"Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).","volume":"53","author":"O\u2019Leary","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi200019r21","article-title":"R: a Language and Environment for Statistical Computing.","author":"Development Core Team","year":"2010"},{"issue":"1","key":"eoi200019r22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data.","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"2","key":"eoi200019r23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ophtha.2010.05.027","article-title":"Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma.","volume":"118","author":"Rao","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi200019r24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ophtha.2010.04.038","article-title":"Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression.","volume":"118","author":"Tanna","year":"2011","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi200019r25","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1167\/iovs.15-16957","article-title":"More accurate modeling of visual field progression in glaucoma: ANSWERS.","volume":"56","author":"Zhu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi200019r26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/BF02539406","article-title":"Visual field progression: comparison of Humphrey Statpac2 and pointwise linear regression analysis.","volume":"234","author":"McNaught","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"eoi200019r27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/APO.0b013e3182531e34","article-title":"Comparison of PROGRESSOR and Glaucoma Progression Analysis 2 to detect visual field progression in treated glaucoma patients.","volume":"1","author":"De Moraes","year":"2012","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"8","key":"eoi200019r28","first-page":"2192","article-title":"Simulation of longitudinal threshold visual field data.","volume":"41","author":"Spry","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9975","key":"eoi200019r29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"eoi200019r30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ogla.2019.01.004","article-title":"Improving the feasibility of glaucoma clinical trials using trend-based visual field progression end points.","volume":"2","author":"Wu","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"issue":"2","key":"eoi200019r31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1167\/iovs.12-10833","article-title":"Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis.","volume":"54","author":"Nassiri","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi200019r32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.7.4.20","article-title":"Comparison of visual field point-wise event-based and global trend-based analysis for detecting glaucomatous progression.","volume":"7","author":"Wu","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"eoi200019r33","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0161-6420(97)30153-5","article-title":"Comparison of methods to detect visual field progression in glaucoma.","volume":"104","author":"Nouri-Mahdavi","year":"1997","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi200019r34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ophtha.2011.08.041","article-title":"Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.","volume":"119","author":"Tanna","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi200019r35","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.1167\/iovs.14-15435","article-title":"Models of glaucomatous visual field loss.","volume":"55","author":"Chen","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi200019r36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0002-9394(86)90457-5","article-title":"The rate of progression of scotomas in glaucoma.","volume":"101","author":"Mikelberg","year":"1986","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"eoi200019r37","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1167\/iovs.13-12236","article-title":"Nonlinear, multilevel mixed-effects approach for modeling longitudinal standard automated perimetry data in glaucoma.","volume":"54","author":"Pathak","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi200019r38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1001\/jamaophthalmol.2016.0118","article-title":"Course of glaucomatous visual field loss across the entire perimetric range.","volume":"134","author":"Otarola","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"eoi200019r39","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1167\/iovs.10-6414","article-title":"A method to measure and predict rates of regional visual field decay in glaucoma.","volume":"52","author":"Caprioli","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi200019r40","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1167\/iovs.05-0006","article-title":"Converting to SITA-standard from full-threshold visual field testing in the follow-up phase of a clinical trial.","volume":"46","author":"Musch","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi200019r41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.5.2.12","article-title":"Enhancement of visual field predictions with pointwise exponential regression (PER) and pointwise linear regression (PLR).","volume":"5","author":"Morales","year":"2016","journal-title":"Transl Vis Sci Technol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2763869\/jamaophthalmology_salazar_2020_oi_200019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T02:44:32Z","timestamp":1589510672000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2763869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.0647","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}